YTHDF2 and metabolic dysfunction-associated steatotic liver disease: Similarly, in clinical samples, we found that deterioration of NAFLD grading and an increase in circ‐SLC9A6 were associated with a decrease in YTHDF2 (Figure 3E,F), suggesting that YTHDF2 may be a potential m6A protein that affects the expression of circ‐SLC9A6 in NAFLD.